New biomarkers could help detect lupus nephritis earlier

New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.

DOAC Monotherapy Bests Dual Antithrombotic Therapy for Afib Plus Coronary Disease

LONDON — For patients with atrial fibrillation (Afib) and stable coronary artery disease (CAD), edoxaban (Savaysa) monotherapy improved net outcomes weighing together bleeding and ischemic

September 2, 2024

Simple symptom management support improves wellbeing after heart transplant

When a patient with heart failure has received a new heart and survives – the transplantation is deemed a success.

November 5, 2024

EC approves Celltrion’s Omlyclo for allergic conditions

Omlyclo is approved for the treatment of chronic spontaneous urticaria, allergic asthma and chronic rhinosinusitis with nasal polyps. Credit: voronaman / Shutterstock.com. The European Commission

May 24, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.